Results 61 to 70 of about 11,950 (166)

Cardiorenal Outcomes of Dapagliflozin vs. Empagliflozin in Advanced Chronic Kidney Disease and Diabetes

Clinical Pharmacology &Therapeutics, Volume 120, Issue 1, Page 168-177, July 2026.
Target trial emulation of a multi‐institutional electronic health record network showed comparable cardiorenal effectiveness and safety of dapagliflozin versus empagliflozin in adults with type 2 diabetes and advanced‐stage chronic kidney disease.
Shih‐Hsuan Lin, Jia‐Jin Chen, Ching‐Chung Hsiao, Yu‐Wei Fang, Meng‐Ting Chen, Ming‐Hsien Tsai, Huang‐Yu Yang   +6 more
wiley   +1 more source

Repurposing of the Cardiovascular Drug Statin for the Treatment of Cancers: Efficacy of Statin–Dipyridamole Combination Treatment in Melanoma Cell Lines

Biomedicines
Metastatic melanoma has a very poor prognosis. Statins, 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR) inhibitors, are cholesterol-lowering agents with a potential for cancer treatment.
Nanami Irie, Kana Mizoguchi, Tomoko Warita, Mirai Nakano, Kasuga Sasaki, Jiro Tashiro, Tomohiro Osaki, Takuro Ishikawa, Zoltán N. Oltvai, Katsuhiko Warita   +9 more
doaj   +1 more source

CD8+ Tissue‐Resident Memory T Cells in Health and Disease

MedComm, Volume 7, Issue 7, July 2026.
CD8+ TRM cells are at the center of immunity, mediating potent local innate and adaptive immune responses. While TRM cells mediate protective immunity against infections and tumors, they also contribute to pathological inflammation in autoimmune conditions.
Yu‐Han Ai, Ting‐Ting Xu, Sen Lin, Meng‐Yu Xiao, Yun‐Xia Lin, Hao‐Wen Ma, Yue‐Yang Liu, Yao‐Jie Wang, Lu‐Ning Yin, Mei Huang, Yong‐Da Liu, Chao Zhu, Xiao‐Ting Zhu, Ji‐Hang Yuan   +13 more
wiley   +1 more source

Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT

Health Technology Assessment, 2018
Background: Two antiplatelet agents are better than one for preventing recurrent stroke after acute ischaemic stroke or transient ischaemic attack (TIA).
Philip M Bath, Lisa J Woodhouse, Jason P Appleton, Maia Beridze, Hanne Christensen, Robert A Dineen, Katie Flaherty, Lelia Duley, Timothy J England, Diane Havard, Stan Heptinstall, Marilyn James, Chibeka Kasonde, Kailash Krishnan, Hugh S Markus, Alan A Montgomery, Stuart Pocock, Marc Randall, Annamarei Ranta, Thompson G Robinson, Polly Scutt, Graham S Venables, Nikola Sprigg   +22 more
doaj   +1 more source

Abstracts from the 2026 joint meeting between MedStar Georgetown University Hospital's Functional Diabetic Limb Salvage: A Team Approach in collaboration with the Wound Healing Foundation, 8‐11th April 2026, Washington, DC, USA

International Wound Journal, Volume 23, Issue 9, September 2026.
Laura K. S. Parnell, John Steinberg
wiley   +1 more source

Phosphodiesterase Inhibition and Immunotropic Activity of Dipyridamole Dynamic Derivatives

Current Issues in Molecular Biology
Introduction. Many pharmacological properties of dipyridamole (DIP) are associated with its ability to inhibit phosphodiesterases (PDEs). Actually, DIP has interesting properties like antiviral for influenza, SARS-2 COVID-19, and herpesviruses.
Artur Martynov, Boris Farber, Alexander Katz   +2 more
doaj   +1 more source

Dipyridamole stress echocardiography combined with pair-wise bicycle stress test and transesophageal atrial stimulation in coronary heart disease diagnostics

Российский кардиологический журнал, 2005
The aim of the study was to identify and compare informative values of combined high-dose dipyridamole stress echocardiography (EchoCG) and pair bicycle stress test, or transesophageal atrial pacing (TEAP), in coronary stenosis diagnostics.
A. Yu. Vasilyev, N. N. Mikheev
doaj  

Experience of using MHT combined with dipyridamole in patients in the early postmenopause

Медицинский совет, 2019
This article presents the evaluation of efficacy of low-dose dipyridamole used to prevent thrombotic complications during menopausal therapy in women in the early postmenopause.
T. M. Sokolova, I. O. Marinkin, V. M. Кuleshov, K. Yu. Makarov   +3 more
doaj   +1 more source

Topic diagnostics of coronary pathology in coronary heart disease patients by contrast stress echocardiography with dipyridamole

Кардиоваскулярная терапия и профилактика, 2005
Aim. To assess diagnostic potential of contrast stress echocardiography (CS-EchoCG) with dipyridamole in coronary heart disease (CHD) patients. Material and methods. The study included 22 patients (mean age 56.04±1.8 years) with typical CHD clinics.
S. T. Matskeplishvili, E. U. Asymbekova, E. A. Ayazyan, V. I. Ioshina, T. V. Kavtiashvili   +4 more
doaj  

Comparison of exercise, dobutamine-atropine and dipyridamole-atropine stress echocardiography in detecting coronary artery disease

Cardiovascular Ultrasound, 2006
Background Dipyridamole and dobutamine stress echocardiography testing are most widely utilized, but their sensitivity remained suboptimal in comparison to routine exercise stress echocardiography.
Petrasinovic Zorica, Saponjski Jovica, Stankovic Goran, Stojkovic Sinisa, Nedeljkovic Milan, Stepanovic Jelena, Djordjevic-Dikic Ana, Beleslin Branko, Ostojic Miodrag, Nedeljkovic Ivana, Giga Vojislav, Mitrovic Predrag   +11 more
doaj   +1 more source